In-patient Asthma Counseling by Pulmonologist and Hospital Re-admission Rate
1 other identifier
interventional
164
0 countries
N/A
Brief Summary
Prospective randomized clinical trial to assess the effect of in-hospital intensive counseling and follow-up vs. usual care, on re-admission rates of patients with Asthma. The study population will include asthma patients admitted to internal Medicine departments and medical ICU at Soroka University Medical Center, due to asthma exacerbation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable asthma
Started Apr 2016
Typical duration for not_applicable asthma
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 20, 2016
CompletedFirst Posted
Study publicly available on registry
March 24, 2016
CompletedStudy Start
First participant enrolled
April 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2019
CompletedMarch 24, 2016
March 1, 2016
2.6 years
March 20, 2016
March 20, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Re-admission rate
Within 6 months after discharge
Study Arms (2)
Intensive counseling by a pulmonologist
EXPERIMENTALCounselor visit during hospitalization, telephone follow up for 4 weeks and a follow up visits.
Usual care
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Males and females ≥ 18 years old.
- Admitted to Internal Medicine at Soroka University Medical Center due to asthma exacerbation.
You may not qualify if:
- Substance abuse (except for tobacco).
- Handicapped or bed ridden patients.
- Patients who don't speak Hebrew, English, Russian or Arabic.
- Other significant respiratory disease such as COPD, interstitial lung disease (as decided by the PI).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 20, 2016
First Posted
March 24, 2016
Study Start
April 1, 2016
Primary Completion
November 1, 2018
Study Completion
November 1, 2019
Last Updated
March 24, 2016
Record last verified: 2016-03